
An Australian pharmaceutical firm that's developing a world first virus-killing nasal spray is set to list on the ASX.
Firebrick Pharma co-founder Dr Peter Molloy told AAP he's been working on the spray, called Nasodine, for almost a decade, as a treatment for the common cold.